Evidence map›Paper›PMID 39572444›Full record

ArticleEJNMMI physics2024

Comparative analysis of positron emitters for theranostic applications based on small bioconjugates highlighting

Elif Hindié, Ulli Köster, Christophe Champion, Paolo Zanotti-Fregonara, Clément Morgat

Abstract read
In one paragraph

Article in EJNMMI physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elif HindiéDepartment of Nuclear Medicine, University Hospital of Bordeaux, Bordeaux, F-33076, France.
Ulli KösterInstitut Laue-Langevin, Grenoble, F-38042, France.
Christophe ChampionUniversity of Bordeaux, CNRS, CEA, CELIA (Centre Lasers Intenses et Applications), UMR 5107, Talence, F-33405, France.
Paolo Zanotti-FregonaraPerceptive Inc, Needham, MA, USA.
Clément MorgatDepartment of Nuclear Medicine, University Hospital of Bordeaux, Bordeaux, F-33076, France. clement.morgat@u-bordeaux.fr.ORCID http://orcid.org/0000-0002-9432-9223

Funding

Horizon 2020 Framework Programme 101008571Université de Bordeaux NewMOON
6 · The paper itself

Abstract

backgroundTargeted radionuclide therapy with

methodsTotal electron and photon doses per decay and per positron; possibly interfering γ-ray emissions; typical activities to be injected for same-day imaging; positron range; and available production routes were examined.

resultsFor each annihilation process useful for PET imaging, the total energy released (MeV) is:

conclusionIn particular,

Indexed as

43Sc45Ti61CuPETTheranostics

Identifiers

PMID39572444
PMCPMC11582248

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.